Additive Orthopaedics, LLC – Trademark Portfolio
Entity Type: 16
Additive Orthopaedics, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DEATHSTAR, GAME PLAN, and ADDITIVE ORTHOPAEDICS. The owner is based in Little Silver, NJ.
PO Box 310
Little Silver, NJ 07739
Showing of trademarks Trademarks
Trademark Classifications
Additive Orthopaedics, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Additive Orthopaedics, LLC have?
Additive Orthopaedics, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 1 cancelled.
What trademark classes does Additive Orthopaedics, LLC file in?
Additive Orthopaedics, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Additive Orthopaedics, LLC's most well-known trademarks?
Additive Orthopaedics, LLC's registered trademark portfolio includes well-known marks such as DEATHSTAR, GAME PLAN, and ADDITIVE ORTHOPAEDICS. These are among 3 currently registered trademarks in the portfolio.
What is Additive Orthopaedics, LLC's trademark registration success rate?
Additive Orthopaedics, LLC has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.